Back to search
FDAFDA · Food and drugs·Recall number D-1161-2017

BevaDex (bevacizumab) 0.06mL Prefilled 32 g (1.25mg/1mg) Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659 (877) BELLA.

Published September 20, 2017 · Recall initiated: August 15, 2017

Summary

FDA records drug Class II recall D-1161-2017, published September 20, 2017 and initiated August 15, 2017. Recalling firm: Bella Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 200 syringes; Lot: Lot #: 08152017, Exp. 11/15/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bella Pharmaceuticals, Inc.
Distributor
Nationwide within USA
Lot
Lot #: 08152017, Exp. 11/15/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BevaDex (bevacizumab) 0.06mL Prefilled 32 g (1.25mg/1mg) Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659 (877) BELLA. recalled?

Yes. FDA published recall D-1161-2017 on September 20, 2017. Reported hazard: Lack of Assurance of Sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone